Common Docking Domain Mutation E322K of the ERK2 Gene is Infrequent in Oral Squamous Cell Carcinomas

Valiathan, Gopalakrishnan Mohan; Thenumgal, Siji Jacob; Jayaraman, Bhaskar; Palaniyandi, Arunmozhi; Ramkumar, Hemalatha; Jayakumar, Keerthivasan; Bhaskaran, Sajeev; Ramanathan, Arvind

추천

검색

자료유형: 학술저널

저자정보: Valiathan, Gopalakrishnan Mohan (Department of Periodontia, Sree Balaji Medical and Dental College and Hospital, Bharath University) Thenumgal, Siji Jacob (Department of Periodontia, Rajah Muthiah Dental College and Hospital, Annamalai University) Jayaraman, Bhaskar (Department of Periodontia, Sree Balaji Medical and Dental College and Hospital, Bharath University) Palaniyandi, Arunmozhi (Department of Periodontia, Rajah Muthiah Dental College and Hospital, Annamalai University) Ramkumar, Hemalatha (Department of Pedodontia, S.R.M Dental College and Hospital, S.R.M University) Jayakumar, Keerthivasan (Human Genetics Laboratory, Sree Balaji Medical and Dental College and Hospital, Bharath University) Bhaskaran, Sajeev (Department of Conservative Dentistry, Vananchal Dental College and Hospital) Ramanathan, Arvind (Human Genetics Laboratory, Sree Balaji Medical and Dental College and Hospital, Bharath University)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제13권 제12호

발행연도: 2012.1

수록면: 6,155 - 6,157 (3page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Mutations in the MAPK (Mitogen Activated Protein Kinase) signaling pathway - EGFR/Ras/RAF/MEK have been associated with the development of several carcinomas. ERK2, a downstream target of the MAPK pathway and a founding member of the MAPK family is activated by cellular signals emanating at the cell membrane. Activated ERK2 translocates into the nucleus to transactivate genes that promote cell proliferation. MKP - a dual specific phosphatase - interacts with activated ERK2 via the common docking (CD) domain of the later to inactivate (dephosphorylate) and effectively terminate further cell proliferation. A constitutively active form of ERK2 carrying a single point mutation - E322K in its CD domain, was earlier reported by our laboratory. In the present study, we investigated the prevalence of this CD domain E322K mutation in 88 well differentiated OSCC tissue samples. Materials and Method: Genomic DNA specimens isolated from 88 oral squamous cell carcinoma tissue samples were amplified with primers flanking the CD domain of the ERK2 gene. Subsequently, PCR amplicons were gel purified and subjected to direct sequencing to screen for mutations. Results: Direct sequencing of eighty eight OSCC samples identified an E322K CD domain mutation in only one (1.1%) OSCC sample. Conclusions: Our result indicates that mutation in the CD domain of ERK2 is rare in OSCC patients, which suggests the role of genetic alterations in other mitogenic genes in the development of carcinoma in the rest of the patients. Nevertheless, the finding is clinically significant, as the relatively rare prevalence of the E322K mutation in OSCC suggests that ERK2, being a common end point signal in the multi-hierarchical mitogen activated signaling pathway may be explored as a viable drug target in the treatment of OSCC.

#Oral squamous cell carcinoma #oral cancer #ERK2 #ERK2 mutation #ERK2 mutation in oral cancer

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요